Cantor Fitzgerald Reaffirms Neutral on Rivian, $15 Price Target

Analyst: Andres Sheppard 1 min read Reproduced verbatim
Rating
Neutral
Unchanged
Target
$15
Unchanged
Outcome
Reached
on January 30, 2026

Cantor’s latest target on Rivian is now $16 (Oct 30, 2026); the median of 12 firms is $18. Cantor has reached 78% of its year-old targets (59 scored).

Cantor and Rivian logos

What the analyst said

Cantor Fitzgerald analyst Andres Sheppard reiterated a Neutral rating and $15 price target on Rivian Automotive Inc (NASDAQ: RIVN).

“On 1/2, RIVN (N) pre-announced that in 4Q it produced 10,974 vehicles, above our estimate/Visible Alpha Consensus of 10,690/9,544, (though below 12,727 in 4Q24), and that it delivered 9,745 vehicles in 4Q25, below our estimate/Visible Alpha Consensus of 9,998/10,086, (and below 14,183 in 4Q24).

For FY25, Rivian produced 42,284 vehicles, which was in line with our estimate of 42,000, above Visible Alpha Consensus of 40,854, though below 49,476 vehicles in FY24.

Additionally, the company delivered 42,247 vehicles for FY25, which was within company guidance of 41,500-43,500, and in line with our estimate of 42,500 (though below 51,579 vehicles in FY24).

Separately, Rivian’s management recently reaffirmed that start of production (SOP) for its upcoming R2 vehicles remains on-track for 1H26. Recall that management previously disclosed an initial R2 annual production capacity of 155,000 vehicles, and a starting price of $45,000 for the lowest trim, (although we expect RIVN to first launch with a higher trim version).

Additionally, management expects the R2 line to “be less than half the cost of revenues per unit,” relative to the R1 line. We continue to expect initial R2 customer deliveries in 3Q26, and we view this as the most material catalyst for this year.

We expect R2 will help to materially boost sales (given the competitive price point and the upcoming autonomy features).”

Cite this note: Price Target, "Cantor Fitzgerald Reaffirms Neutral on Rivian, $15 Price Target," January 5, 2026. https://price-target.com/2026/01/05/179345/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

RIVN trades at $10.33. The 12 analysts who set a target in the last 3 months range from $10 to $23, with a median of $18. This $15 target is 17% below the median.

Since the note RIVN has moved −47% (from $19.41). 12-month window: day 320 of 365, closes on January 5, 2027.

Track record

This call✓ Target reached on January 30, 2026, 2 months after the note. Same target as this firm’s December 12, 2025 note, so it is scored there.

Firm track recordCantor: 78% of its 59 targets at least a year old were reached within 12 months (#15 of 29 firms); on Rivian, 4 of 4. Accuracy ranking →

Cantor on Rivian

Cantor price targets on Rivian

8 calls from October 2, 2025 to February 13, 2026. The target went from $15 to $18 (+20%). The rating stayed Hold.

Cantor targetRIVN share price
  1. February 13, 2026Target raised from $15 (+20%)Hold$18
  2. February 9, 2026Rating only, no price targetHoldNo target
  3. January 5, 2026 This noteKept the $15 targetHold$15
  4. January 2, 2026Kept the $15 targetHold$15
  5. December 12, 2025Kept the $15 targetHold$15
  6. November 5, 2025Kept the $15 targetHold$15
  7. October 6, 2025Kept the $15 targetHold$15
  8. October 2, 2025Earliest call shownHold$15
Share Reddit StockTwits
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.